logo
Select company
Select metric
-1668.88%EBIT Margin
VS
Market
5
Sector
17
Industry
31
History
100
$ 1.11Close
$ 0.77 - $ 1.54 52-Week Range
Ticker Information

Ticker

RNXT

Company Name

RENOVORX INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

RENOVORX INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RNXT - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -11.05M-1668.88%$ 662K
3/31/2025$ -10.54M-4392.5%$ 240K
12/31/2024$ -9.2M-21390.7%$ 43K
9/30/2024$ -9.05M0%$ 0
6/30/2024$ -8.01M0%$ 0
3/31/2024$ -7.94M0%$ 0
12/31/2023$ -10.12M0%$ 0
9/30/2023$ -9.18M0%$ 0
6/30/2023$ -9.91M0%$ 0
3/31/2023$ -10.2M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • RENOVORX INC's latest trailing twelve months (TTM) EBIT % stands at 0%.
  • Over the past 5 years, RENOVORX INC's average EBIT % has been -9150.69%.
  • The median EBIT % for RENOVORX INC during this period was -4392.5%
  • RENOVORX INC reached its highest EBIT % over the past 5 years at -1668.88%.
  • The lowest EBIT % recorded by RENOVORX INC in the same timeframe -21390.7%

RENOVORX INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
ADVM : ADVERUM BIOTECHNOLOGIES INC -18387.4%RLYB : RALLYBIO CORP -5473.32%ICU : SEASTAR MEDICAL HOLDING CORP -1909.79%LEXX : LEXARIA BIOSCIENCE CORP -1849.39%CLNN : CLENE INC -9398.6%COEP : COEPTIS THERAPEUTICS HOLDINGS INC -3832.35%BRTX : BIORESTORATIVE THERAPIES INC -1771.91%VTGN : VISTAGEN THERAPEUTICS INC -8633.59%LYRA : LYRA THERAPEUTICS INC -5041.17%SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC -1339.78%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for RENOVORX INC is calculated as follows: EBIT [ $ -3.21M ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ]

RNXT - EBIT Margin, Last 5 years

-21390.7%

Minimum

Dec 31, 2024

-1668.88%

Maximum

Jun 30, 2025

-9150.69%

Average

-4392.5%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%